Bristol-Myers (BMY) Adds $3B in Shares to Buyback Plan
Tweet Send to a FriendGet Alerts BMY Hot Sheet
Price: $44.06 +0.69%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.4%
Revenue Growth %: -27.0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.4%
Revenue Growth %: -27.0%
Trade BMY Now!
Bristol-Myers (NYSE: BMY) adds $3 billion in shares to its buyback plan.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Elliott Management: Dividend, Buyback are 'Positive Steps' for NetApp (NTAP)
- RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Create E-mail Alert Related Categories
Stock Buybacks
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
